Skip to main content
Clinical Trials/NL-OMON38496
NL-OMON38496
Not yet recruiting
Not Applicable

Cardiovascular risk profile in pediatric CAH patients: a cross-sectional study - Cardiovascular risk in CAH

niversitair Medisch Centrum Sint Radboud0 sites80 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congenital aderenal hyperplasia
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
80
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • CAH due to 21\-hydroxylase deficiency, biochemical and genetically proven
  • Age: 1\-16 years

Exclusion Criteria

  • CAH due to other enzym deficiency
  • Refusal to participate by patient/parents
  • Known co\-morbidity: cardiac disease, renal disease, co\-medication that interferes with blood pressure

Outcomes

Primary Outcomes

Not specified

Similar Trials